# ALK33-001: A Study of RDC-0313 Administered to Healthy Adults

> **NCT00800319** · PHASE1 · COMPLETED · sponsor: **Alkermes, Inc.** · enrollment: 16 (actual)

## Conditions studied

- Alcohol Dependence

## Interventions

- **DRUG:** RDC-0313
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00800319
- **Lead sponsor:** Alkermes, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-02
- **Final completion:** 2009-06
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2011-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00800319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00800319, "ALK33-001: A Study of RDC-0313 Administered to Healthy Adults". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00800319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*